HIRSCHHORN MARK 4

4 · Teladoc Health, Inc. · Filed Dec 17, 2018

Form 4

Period: 2018-12-13

Executive VP and CFO

Transactions

Exercise/Conversion
Common Stock
2018-12-13$6.01/sh+684$4,111→ 4,342 total
Exercise/Conversion
Common Stock
2018-12-13$12.21/sh+3,081$37,619→ 9,707 total
Exercise/Conversion
Common Stock
2018-12-13$1.67/sh+1,001$1,672→ 3,658 total
Exercise/Conversion
Employee Stock Option (right to buy)
2018-12-13−2,284→ 29,692 total
Exercise: $6.01Exp: 2024-12-22→ Common Stock (2,284 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2018-12-13−293→ 102,352 total
Exercise: $22.30Exp: 2027-03-03→ Common Stock (293 underlying)
Exercise/Conversion
Common Stock
2018-12-13$6.01/sh+2,284$13,727→ 6,626 total
Exercise/Conversion
Common Stock
2018-12-13$22.30/sh+293$6,534→ 10,000 total
Exercise/Conversion
Employee Stock Option (right to buy)
2018-12-13−684→ 6,151 total
Exercise: $6.01Exp: 2024-09-10→ Common Stock (684 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2018-12-13−1,001→ 7,008 total
Exercise: $1.67Exp: 2023-12-11→ Common Stock (1,001 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2018-12-13−3,081→ 83,194 total
Exercise: $12.21Exp: 2026-03-07→ Common Stock (3,081 underlying)

Footnotes (5)

[F1]The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter.
[F2]The option vests as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
[F3]The option vests as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
[F4]The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
[F5]The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Documents

1 file